Israel - English - Ministry of Health

rafa laboratories ltd - acarbose - tablets - acarbose 100 mg - acarbose - acarbose - treatment of non-insulin dependent diabetes mellitus (niddm) in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - acarbose, quantity: 100 mg - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; pregelatinised maize starch - as an adjunct to prescribed diet and exercise for the management of blood glucose concentrations in non-insulin dependent diabetic patients who are inadequately controlled by diet alone or by diet and oral hypoglycaemic agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - acarbose, quantity: 50 mg - tablet - excipient ingredients: pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose - as an adjunct to prescribed diet and exercise for the management of blood glucose concentrations in non-insulin dependent diabetic patients who are inadequately controlled by diet alone or by diet and oral hypoglycaemic agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - acarbose, quantity: 100 mg - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; pregelatinised maize starch - as an adjunct to prescribed diet and exercise for the management of blood glucose concentrations in non-insulin dependent diabetic patients who are inadequately controlled by diet alone or by diet and oral hypoglycaemic agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - acarbose, quantity: 50 mg - tablet - excipient ingredients: magnesium stearate; pregelatinised maize starch; colloidal anhydrous silica; microcrystalline cellulose - as an adjunct to prescribed diet and exercise for the management of blood glucose concentrations in non-insulin dependent diabetic patients who are inadequately controlled by diet alone or by diet and oral hypoglycaemic agents.

Malta - English - Medicines Authority

bayer public limited company 400 south oak way, reading berkshire rg2 6ad, united kingdom - acarbose - tablet - acarbose 50 mg - drugs used in diabetes

Malta - English - Medicines Authority

bayer public limited company 400 south oak way, reading berkshire rg2 6ad, united kingdom - acarbose - tablet - acarbose 100 mg - drugs used in diabetes

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - acarbose 100mg - tablet - 100 mg - active: acarbose 100mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose - indicated for the additional treatment of insulin dependent and non-insulin dependent diabetes mellitus in association with diet.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - acarbose 50mg - tablet - 50 mg - active: acarbose 50mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose - indicated for the additional treatment of insulin dependent and non-insulin dependent diabetes mellitus in association with diet.

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - acarbose 100mg;   - tablet - 100 mg - active: acarbose 100mg   excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose pregelatinised maize starch - indicated for the additional treatment of insulin dependent and non-insulin dependent diabetes mellitus in association with diet.